Literature DB >> 8442529

Raynaud's syndrome, an enigma after 130 years.

T J Cleophas1, M G Niemeyer.   

Abstract

The recent literature concerning Raynaud's syndrome is reviewed. Raynaud's syndrome is as common as hypertension and diabetes. In spite of its generally benign character, it causes a lot of discomfort to individuals and sickness absenteeism to society, especially in the colder regions of the world. The etiology remains an enigma 130 years after its first description, perhaps even more so than ever before, the many new theories proposed in the literature. Clearly, in a condition where seventy different etiologic theories are advocated, the culprit lesion is obviously missing, or there is not a culprit lesion but an accumulation of conditions having nothing in common but a few symptoms. Moreover a Raynaud attack may result, not from a single event, but from a cascade of events, just as, for example, hemostasis does. Controversy about diagnosis exists all over. For example, how does one make a diagnosis? Patient history has been considered unreliable. A standardized cold test, though highly reproducible in the authors' hands, is far from common property. Raynaud's syndrome is a condition for which thirty-eight therapies have been advocated in the last three years, but the curative answer is still to come.

Entities:  

Mesh:

Year:  1993        PMID: 8442529     DOI: 10.1177/000331979304400305

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  2 in total

1.  [Maurice Raynaud (1834-1881) and the syndrome named after him].

Authors:  H Kaiser
Journal:  Z Rheumatol       Date:  2011-09       Impact factor: 1.372

2.  Effect of isradipine on endothelin-1 plasma concentrations in patients with Raynaud's phenomenon.

Authors:  L La Civita; D Giuggioli; M G Del Chicca; G Longombardo; G Pasero; C Ferri
Journal:  Ann Rheum Dis       Date:  1996-05       Impact factor: 19.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.